Prostate Tumor Progression Dictated by Cancer’s Gene-determined “Immune Landscape”

News   Jan 15, 2018 | Original story from Beth Israel Deaconess Medical Center

 
Prostate Tumor Progression Dictated by Cancer’s Gene-determined “Immune Landscape”

Wild type human prostate cells from an organoid (a man-made construct that resembles an organ). These cells have come from a xenograft where they serve as controls for the study of primary prostate cancer tumor cells, which are also injected into mice and then extracted for characterization. Credit: National Cancer Institute, National Institutes of Health

 
 
 

RELATED ARTICLES

Drug Transport Gene May Explain Why Ovarian Cancer Patients React Differently to Chemotherapy

News

A gene which produces a protein that transports drugs in and out of cells may explain why some women treated with chemo have serious side effects.

READ MORE

Tiny Kidneys: Building Better Models to Test Drugs

News

A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

READ MORE

DETECTR Sniffs Out DNA Signals Using CRISPR-Cas9's Cousin

News

A new technology allows amplification and detection of genomic snippets present in a sample, using the enzyme Cas12.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE